SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) — Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) SIGY, a development-stage company that creates therapeutic blood purification candidates to overcome clearly defined limitations in healthcare, today announced that Jim Joyce, Chairman and CEO, will present live at the OTCQB Venture Virtual Investor Conference…Read More
Sigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rd Sigyn Therapeutics OTCSIGY
